Abstract:Objective To investigate the pharmacokinetics and bioavailability of self-prepared dexibuprofen sustained release capsules and reference formulation in rats.Methods An RP-HPLC method was established to determine the concentration of dexibuprofen in plasma.Dexibuprofen sustained release capsule was prepared,and its pharmacokinetic parameters and bioavailability in SD rats were studied after oral administration.Results The pharmacokinetics parameters of dexibuprofen showed that Cmax was(1 173.87±281.68) and(1 186.06±268.79) μg·mL-1,AUC(0-t)(4 276.53±578.59) and(4 489.83±645.73) mg·L-1·h,AUC(0-∞)(5 095.58±683.82) and(5 466.37±753.35) mg·L-1·h,tmax(1.33±0.26) and(1.58±0.49) h for self-prepared dexibuprofen sustained release capsules and reference formulation,respectively.There was no significant difference between the parameters of the two formulations(P>0.05).The relative bioavailability of self-prepared dexibuprofen sustained release capsules to reference formulation is(93.2±12.5)%.Conclusion The results of statistical analysis show that self-prepared dexibuprofen sustained release capsules and reference formulation are bioequivalent.

Pharmacokinetics and Bioavailability of Dexibuprofen Sustained Release Capsules in Rats